These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 20854812

  • 21. Protection by tetrahydroxystilbene glucoside against neurotoxicity induced by MPP+: the involvement of PI3K/Akt pathway activation.
    Qin R, Li X, Li G, Tao L, Li Y, Sun J, Kang X, Chen J.
    Toxicol Lett; 2011 Apr 10; 202(1):1-7. PubMed ID: 21237255
    [Abstract] [Full Text] [Related]

  • 22. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug 10; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

  • 23. Extract of Cassiae Semen and its major compound inhibit S100b-induced TGF-beta1 and fibronectin expression in mouse glomerular mesangial cells.
    Jung DH, Kim YS, Kim NH, Lee J, Jang DS, Kim JS.
    Eur J Pharmacol; 2010 Sep 01; 641(1):7-14. PubMed ID: 20483351
    [Abstract] [Full Text] [Related]

  • 24. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
    Lai PB, Zhang L, Yang LY.
    Ren Fail; 2012 Sep 01; 34(1):83-7. PubMed ID: 22011322
    [Abstract] [Full Text] [Related]

  • 25. Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1.
    Chen LL, Zhang JY, Wang BP.
    Vascul Pharmacol; 2006 May 01; 44(5):309-15. PubMed ID: 16624630
    [Abstract] [Full Text] [Related]

  • 26. Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats.
    Surse VM, Gupta J, Tikoo K.
    J Mol Endocrinol; 2011 Jun 01; 46(3):245-54. PubMed ID: 21450970
    [Abstract] [Full Text] [Related]

  • 27. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway.
    Kuhad A, Chopra K.
    Life Sci; 2009 Feb 27; 84(9-10):296-301. PubMed ID: 19162042
    [Abstract] [Full Text] [Related]

  • 28. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats.
    Hao HH, Shao ZM, Tang DQ, Lu Q, Chen X, Yin XX, Wu J, Chen H.
    Life Sci; 2012 Nov 02; 91(19-20):959-67. PubMed ID: 23000098
    [Abstract] [Full Text] [Related]

  • 29. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
    Ju KD, Shin EK, Cho EJ, Yoon HB, Kim HS, Kim H, Yang J, Hwang YH, Ahn C, Oh KH.
    Am J Physiol Renal Physiol; 2012 Mar 01; 302(5):F606-13. PubMed ID: 22129969
    [Abstract] [Full Text] [Related]

  • 30. [Effect of berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy].
    Tang L, Lv F, Liu S, Zhang S.
    Zhongguo Zhong Yao Za Zhi; 2011 Dec 01; 36(24):3494-7. PubMed ID: 22368864
    [Abstract] [Full Text] [Related]

  • 31. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM, del Re E, Brown D, Lin HY.
    Diabetes; 2007 Feb 01; 56(2):380-8. PubMed ID: 17259382
    [Abstract] [Full Text] [Related]

  • 32. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat.
    Pessôa BS, Peixoto EB, Papadimitriou A, Lopes de Faria JM, Lopes de Faria JB.
    J Renin Angiotensin Aldosterone Syst; 2012 Mar 01; 13(1):56-66. PubMed ID: 21987533
    [Abstract] [Full Text] [Related]

  • 33. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Mar 01; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 34. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.
    Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, Arozal W, Sukumaran V, Lakshmanan AP, Arumugam S, Suzuki K.
    Mol Nutr Food Res; 2011 Nov 01; 55(11):1655-65. PubMed ID: 22045654
    [Abstract] [Full Text] [Related]

  • 35. Therapeutic potential of angiostatin in diabetic nephropathy.
    Zhang SX, Wang JJ, Lu K, Mott R, Longeras R, Ma JX.
    J Am Soc Nephrol; 2006 Feb 01; 17(2):475-86. PubMed ID: 16394111
    [Abstract] [Full Text] [Related]

  • 36. The crosstalk between Sirt1 and Keap1/Nrf2/ARE anti-oxidative pathway forms a positive feedback loop to inhibit FN and TGF-β1 expressions in rat glomerular mesangial cells.
    Huang K, Gao X, Wei W.
    Exp Cell Res; 2017 Dec 01; 361(1):63-72. PubMed ID: 28986066
    [Abstract] [Full Text] [Related]

  • 37. Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway.
    Lan T, Liu W, Xie X, Huang K, Peng J, Huang J, Shen X, Liu P, Yang H, Huang H.
    Eur J Pharmacol; 2012 Dec 15; 697(1-3):165-72. PubMed ID: 23085271
    [Abstract] [Full Text] [Related]

  • 38. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-glucoside, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice.
    Wang X, Zhao L, Han T, Chen S, Wang J.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):339-48. PubMed ID: 17963744
    [Abstract] [Full Text] [Related]

  • 39. Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats.
    Su J, Zhang P, Zhang JJ, Qi XM, Wu YG, Shen JJ.
    Phytomedicine; 2010 Mar 14; 17(3-4):254-60. PubMed ID: 19758795
    [Abstract] [Full Text] [Related]

  • 40. Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway.
    Huang J, Huang K, Lan T, Xie X, Shen X, Liu P, Huang H.
    Mol Cell Endocrinol; 2013 Jan 30; 365(2):231-40. PubMed ID: 23127801
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.